GeneDx Holdings Corp. (Nasdaq: WGS) has announced the upcoming introduction of its proprietary dataset, GeneDx Infinity™, at the American Academy of Pediatrics $(AAP)$ National Conference & Exhibition, taking place September 26 to 30 in Denver, CO. GeneDx Infinity is the largest rare disease dataset of its kind, comprising data from over 2.5 million genomic patients, including nearly 1 million exomes and genomes, and millions of phenotypic datapoints. The company highlights Infinity's unmatched scale, depth, and diversity, which enable more accurate and equitable genetic diagnoses, particularly for children with rare diseases. The dataset underpins GeneDx's ExomeDx and GenomeDx diagnostic tests and continues to grow in power and impact with each new test. The research results and applications of Infinity will be presented to pediatricians at the upcoming AAP conference.